Clinical Trial Update: Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis [NA]

View source ↗

Summary

Clinical trial update about the FibroScan medical device for non-invasive assessment of liver steatosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Steatosis

Drugs mentioned

• FibroScan

Snippet

Sponsor: University Hospital, Tours | Conditions: Liver Steatosis | NA | Status: UNKNOWN